Anitoa Systems has introduced Maverick, an ultra-portable quantitative-polymerase-chain-reaction (qPCR) system.

At less than 1 kilo-gram in a handheld format, Maverick is created to facilitate point-of-care molecular testing for both medical and non-medical applications.

Maverick is packed with technology innovations from Anitoa, a young Silicon Valley medical device company. These innovations include a unique proprietary low-light sensitive, complementary metal-oxide-semiconductor (CMOS) 4-channel fluorescence optics system that allows fast and highly multiplexed DNA detection without the need for field calibration.

Maverick is further enhanced with a cloud-based software that is seamlessly connected to the Internet, and enables cloud data storage and retrieval. Maverick software also includes a machine learning technology-ready data analytics engine.

Applications of Maverick include near-patient diagnostics, food, agriculture and environment testing, forensics, and basic biological research. Anitoa has previously demonstrated Maverick technology in detecting several types of pathogen DNA and RNA strands, such as Hepatitis B and C, HIV, E. coli and many of their drug-resistant variants.

Maverick has been shown to achieve reliable detection of only 4 copies pathogen molecule DNA per sample with over 9 orders of magnitude in dynamic range.

Anitoa Systems CEO Dr. Zhimin Ding said: "We are excited to bring to the market a portable qPCR device with performance that rivals the most expensive lab-based systems, at a fraction of the cost.”

"We strive to make our molecular testing systems rugged, accessible, and with battery operation and power-loss protection capability to facilitate their effective use in low resource settings."

Anitoa Systems, a medical device technology start-up established in 2013 with headquarter in Menlo Park, California, develops highly-integrated and low-power CMOS-based bio-sensor devices for fluorescence and chemiluminescence-based molecular imaging.